Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.18 USD -4.21% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supernus Pharmaceuticals Inc
Long-Term Investments Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Long-Term Investments
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Long-Term Investments
$505m
CAGR 3-Years
-35%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Long-Term Investments
$2.4B
CAGR 3-Years
-20%
CAGR 5-Years
18%
CAGR 10-Years
-6%
Pfizer Inc
NYSE:PFE
Long-Term Investments
$11.1B
CAGR 3-Years
-20%
CAGR 5-Years
-10%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Long-Term Investments
$1.8B
CAGR 3-Years
20%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
Eli Lilly and Co
NYSE:LLY
Long-Term Investments
$3.2B
CAGR 3-Years
-2%
CAGR 5-Years
12%
CAGR 10-Years
-8%

See Also

What is Supernus Pharmaceuticals Inc's Long-Term Investments?
Long-Term Investments
0 USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Long-Term Investments amounts to 0 USD.

Back to Top